The value of early diagnosis

 

MOPEAD communication team  has released an infographic on the ‘Value of Early Diagnosis’. The MOPEAD project is designed to assess different patient engagement models across Europe, to identify efficient approaches of earlier identification of mild Alzheimer’s disease (AD) dementia and prodromal AD patients. 

 

The infographics are designed to support the understanding of the need for such approaches, emphasises the benefits of a timely diagnosis for patients and families as well as healthcare providers and advantages on a societal level. Concrete examples and statements amplify these areas.

Take a look at the infographic.

 

More infographics...

Share on Facebook
Share on Twitter
Please reload

Please reload

Archive
Please reload

Search By Tags
Please reload

Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

©2018 MOPEAD

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement No 115985. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations